Sherwin CM - Search Results

1

Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children.

Stockmann C, Sherwin CM, Knackstedt ED, Hersh AL, Pavia AT, Spigarelli MG. Stockmann C, et al. Among authors: sherwin cm. J Pediatric Infect Dis Soc. 2016 Jun;5(2):231-232. doi: 10.1093/jpids/piw008. Epub 2016 Mar 8. J Pediatric Infect Dis Soc. 2016. PMID: 26962197 Free PMC article. No abstract available.

2

Optimal study design for pioglitazone in septic pediatric patients.

Sherwin CM, Ding L, Kaplan J, Spigarelli MG, Vinks AA. Sherwin CM, et al. J Pharmacokinet Pharmacodyn. 2011 Aug;38(4):433-47. doi: 10.1007/s10928-011-9202-8. Epub 2011 Jun 11. J Pharmacokinet Pharmacodyn. 2011. PMID: 21667139 Free PMC article.

3

Population pharmacokinetic and pharmacodynamic modeling of high-dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients.

Zobell JT, Stockmann C, Young DC, Cash J, McDowell BJ, Korgenski K, Sherwin CM, Spigarelli M, Chatfield BA, Ampofo K. Zobell JT, et al. Among authors: sherwin cm. Clin Ther. 2011 Nov;33(11):1844-50. doi: 10.1016/j.clinthera.2011.09.010. Epub 2011 Oct 21. Clin Ther. 2011. PMID: 22018680

4

Fundamentals of population pharmacokinetic modelling: modelling and software.

Kiang TK, Sherwin CM, Spigarelli MG, Ensom MH. Kiang TK, et al. Among authors: sherwin cm. Clin Pharmacokinet. 2012 Aug 1;51(8):515-25. doi: 10.2165/11634080-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22676301 Review.

5

Fundamentals of population pharmacokinetic modelling: validation methods.

Sherwin CM, Kiang TK, Spigarelli MG, Ensom MH. Sherwin CM, et al. Clin Pharmacokinet. 2012 Sep 1;51(9):573-90. doi: 10.1007/BF03261932. Clin Pharmacokinet. 2012. PMID: 22799590 Review.

6

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems.

Zobell JT, Young DC, Waters CD, Stockmann C, Ampofo K, Sherwin CM, Spigarelli MG. Zobell JT, et al. Among authors: sherwin cm. Pediatr Pulmonol. 2012 Dec;47(12):1147-58. doi: 10.1002/ppul.22655. Epub 2012 Aug 21. Pediatr Pulmonol. 2012. PMID: 22911974 Review.

7

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium.

Young DC, Zobell JT, Waters CD, Ampofo K, Stockmann C, Sherwin CM, Spigarelli MG. Young DC, et al. Among authors: sherwin cm. Pediatr Pulmonol. 2013 Jan;48(1):1-7. doi: 10.1002/ppul.22664. Epub 2012 Sep 4. Pediatr Pulmonol. 2013. PMID: 22949160

8

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones.

Stockmann C, Sherwin CM, Zobell JT, Young DC, Waters CD, Spigarelli MG, Ampofo K. Stockmann C, et al. Among authors: sherwin cm. Pediatr Pulmonol. 2013 Mar;48(3):211-20. doi: 10.1002/ppul.22667. Epub 2012 Sep 4. Pediatr Pulmonol. 2013. PMID: 22949224 Review.

9

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins.

Zobell JT, Waters CD, Young DC, Stockmann C, Ampofo K, Sherwin CM, Spigarelli MG. Zobell JT, et al. Among authors: sherwin cm. Pediatr Pulmonol. 2013 Feb;48(2):107-22. doi: 10.1002/ppul.22669. Epub 2012 Sep 4. Pediatr Pulmonol. 2013. PMID: 22949297 Review.

10

Metabolic and toxicological considerations for sepsis drug treatments.

Campbell SC, Spigarelli MG, Courter J, Sherwin CM. Campbell SC, et al. Among authors: sherwin cm. Expert Opin Drug Metab Toxicol. 2013 Jan;9(1):79-89. doi: 10.1517/17425255.2012.727396. Epub 2012 Sep 24. Expert Opin Drug Metab Toxicol. 2013. PMID: 22998292 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters